Want to join the conversation?
Global pharmaceutical company $AGN acquired $KYTH in an all-cash transaction valued at approx. $2.1Bil. This deal adds KYBELLA (deoxycholic acid) injection for treatment of double-chin in adults and $KYTH's development product setipiprant (KYTH-105), a novel compound for the prevention of androgenetic alopecia to the $AGN's portfolio of offerings.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?